## Iodinated Contrast Media Classification ### Osmolality and Risk Profile | Parameter | HOCM | LOCM | IOCM | |-----------|------|------|------| | Osmolality (mOsm/kg) | >1400 | 600–800 | ~290 (iso-osmolal) | | Ionicity | Ionic | Non-ionic | Non-ionic | | Nephropathy risk | High | Low | Lower (not zero) | | Thrombophlebitis | High | Low | Low | | Cost | Low | Moderate | High | **Key Point:** Although IOCM have osmolality equal to plasma and theoretically offer the best safety profile, they do NOT completely eliminate contrast-induced nephropathy (CIN) risk. Renal injury can still occur through direct tubular toxicity, oxidative stress, and medullary hypoxia—mechanisms independent of osmolality alone. **High-Yield:** LOCM are now the standard for most patients; IOCM are reserved for very high-risk groups (severe renal impairment, diabetes, elderly, dehydration) when the clinical benefit justifies the cost. ### Why Each Statement Is Correct (Except Option 2) 1. **HOCM risk profile** — Correct. HOCM cause osmotic diuresis, fluid shifts, and endothelial injury; they are now rarely used except in non-vascular applications. 2. **LOCM preference** — Correct. Non-ionic LOCM reduce ionic load and osmotic stress; they are the default choice in modern practice. 3. **IOCM and CIN risk** — **INCORRECT.** IOCM reduce but do NOT eliminate CIN. Nephropathy persists through direct cellular toxicity and ischemic mechanisms. 4. **Ionic contrast adverse effects** — Correct. Ionic agents trigger mast cell degranulation, histamine release, and hemodynamic instability; they are contraindicated in high-risk patients. **Clinical Pearl:** Even with IOCM, adequate hydration, metformin hold (if eGFR <60), and minimization of contrast volume remain essential in renal-impaired patients. [cite:Harrison 21e Ch 297]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.